Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 14/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL687480 | 0.92 | CTSA (0.36) | CTSAMEN1KMT2AHPGDALDH1A1 | |
| SCHEMBL688603 | 0.90 | KMT2A (0.36) | CTSAMEN1KMT2AHPGDALDH1A1 | |
| SCHEMBL687910 | 0.89 | MEN1 (0.39) | CTSAMEN1KMT2AHPGDALDH1A1 | |
| SCHEMBL686719 | 0.87 | MEN1 (0.38) | MEN1KMT2AHPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL687969 | 0.84 | CTSA (0.36) | CTSAMEN1KMT2AHPGDKEAP1 | |
| SCHEMBL688106 | 0.84 | KMT2A (0.41) | CTSAMEN1KMT2AHPGDALDH1A1 | |
| SCHEMBL687167 | 0.84 | KMT2A (0.37) | MEN1KMT2AHPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL686618 | 0.84 | KMT2A (0.37) | MEN1KMT2AHPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL687331 | 0.83 | MEN1 (0.41) | CTSAMEN1KMT2AHPGDALDH1A1 | |
| SCHEMBL687363 | 0.83 | MEN1 (0.41) | CTSAMEN1KMT2AHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1203766-B1 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | ENCYSIVE PHARMACEUTICALS INC (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-1203766-A2 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2002-05-08 | — | — | EP | disclosed |